Details for Patent: 4,395,421

✉ Email this page to a colleague

Summary for Patent: 4,395,421

Patent landscape, scope, and claims:

Title:	Disodium cromoglycate formulations
Abstract:	There is described disodium cromoglycate in a form having a bulk density of greater than 0.45 g per ml when measured according to British Standard Test No 1460 (1967). There are also described granular and unit dosage forms of disodium cromoglycate. The disodium cromoglycate is useful, e.g. in the treatment of certain conditions of the gastrointestinal tract.
Inventor(s):	Taylor; James E. (Loughborough, GB2), Stevenson; Neil A. (Loughborough, GB2)
Assignee:	Fisons Limited (Ipswich, GB2)
Application Number:	06/067,104
Patent Claim Types: see list of patent claims	Formulation; Compound; Dosage form; Composition; Use;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 4,395,421

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 4,395,421

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	43054/76	Oct 16, 1976

International Family Members for US Patent 4,395,421

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2898377	⤷ Subscribe
Australia	508134	⤷ Subscribe
Belgium	858858	⤷ Subscribe
Canada	1133830	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.